Athersys.com
Patient Enrollment Begins in Third and Final Cohort of the Phase 2
WebAthersys, Inc. (NASDAQ: ATHX), a regenerative medicine company developing MultiStem ® (invimestrocel) cell therapy for critical care indications, …
Actived: Just Now
Top Categories
Popular Searched
› Opm health benefit comparison tool
› Health benefits baked potato
› Termination of health insurance coverage
Recently Searched
› Essentia health pharmacy refill form
› Broadstep behavioral health lumberton
› Civitas health services sandston va
› Why eating healthy food is important
› Health and disability flash cards
› Continuing healthcare and benefits
› Literature review for healthcare students